PRC1 and familial pancreatic carcinoma: To further investigate the role of PRC1 in pancreatic cancer, a genetic mouse model, such as Kras (G12D) with Tp53 mutations (KPC model), incorporating PRC1 alterations could be valuable for confirming the involvement of PRC1 in the disease’s progression.